Do you want to share your passion for science? FameLab France needs you!
FameLab, the international science communication competition, is launching in France for the first time in 2014 in partnership with AMSCTI, Inserm, CNES, CERN and Paris Diderot – Sorbonne Paris Cité University. Previous candidates have answered questions such as « Will we ever live on Mars? », « Can maths explain the universe? » and «Is 3D printing the second industrial revolution ? ». Candidates, whether researchers or doctoral students, must present their chosen subject in 3 minutes. A panel comprising of science, media, research and public relations professionals will judge each presentation according to the golden 3Cs rule : Content, Clarity and Charisma.
The closing date for all applications is 28 February 2014 (information on http://www.britishcouncil.fr/en/famelab). Regional selections will take place in Lille in association with the Forum Départemental des Sciences, Annecy with the Turbine and the LAPP/LAPTh, Toulouse with Science Animation, and Paris with Paris Diderot – Sorbonne Paris Cité University. The national final will take place in Paris at the end of April at Paris Diderot – Sorbonne Paris Cité University.
FameLab gives candidates the opportunity to:
– meet and connect with other science enthusiasts and become part of the FameLab France and FameLab International network
– share their passion for science with the public
The finalists will win a 2-day masterclass in science communication at CERN in Geneva, working with UK and French science communicators and media trainers to develop their media and presentation skills.
The national finalist chosen in Paris will represent France in the FameLab International final at the Cheltenham Science Festival in the UK in June, competing with candidates from 25 countries.
What the participants say…..
The European Patents Office (EPO) has just published its annual rankings: For the first time, Inserm has taken the top ranking for applicants in the pharmaceutical sector ahead of the big industrial companies and can confirm at the same time its top ...
The respective classifications of the European Patent Office (EPO) and France's National Industrial Property Institute (INPI), which have just published their annual rankings for 2017, have confirmed Inserm's ability to innovate. Inserm placed first among patent applicants in the pharmaceutical sector for ...